Form4insider filings, from the source

SEC Form 4 · accession 0001645627-17-000052

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
May 2, 2017
Accepted (ET)
May 4, 2017 · 3:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMay 2, 2017P1,000$0.08A20,550,949D
Common StockMay 2, 2017P700$0.08A20,551,649D
Common StockMay 2, 2017P300$0.081A20,551,949D
Common StockMay 2, 2017P1,000$0.081A20,552,949D
Common StockMay 2, 2017P1,000$0.08A20,553,949D
Common StockMay 2, 2017P1,000$0.08A20,554,949D
Common StockMay 2, 2017P1,000$0.08A20,555,949D
Common StockMay 2, 2017P1,000$0.0775A20,556,949D
Common StockMay 2, 2017P1,000$0.08A20,557,949D
Common StockMay 2, 2017P1,000$0.08A20,558,949D
Common StockMay 2, 2017P1,000$0.08A20,559,949D
Common StockMay 2, 2017P1,000$0.08A20,560,949D
Common StockMay 2, 2017P1,000$0.08A20,561,949D
Common StockMay 2, 2017P1,000$0.08A20,562,949D
Common StockMay 2, 2017P1,000$0.08A20,563,949D
Common StockMay 2, 2017P1,000$0.08A20,564,949D
Common StockMay 2, 2017P1,000$0.08A20,565,949D
Common StockMay 2, 2017P1,000$0.081A20,566,949D
Common StockMay 2, 2017P1,000$0.081A20,567,949D
Common StockMay 2, 2017P1,000$0.081A20,568,949D
Common StockMay 2, 2017P1,000$0.082A20,569,949D
Common StockMay 2, 2017P1,000$0.082A20,570,949D
Common StockMay 2, 2017P1,000$0.0819A20,571,949D
Common StockMay 2, 2017P1,000$0.083A20,572,949D
Common StockMay 2, 2017P1,000$0.083A20,573,949D
Common StockMay 2, 2017P1,000$0.083A20,574,949D
Common StockMay 3, 2017P1,000$0.079A20,575,949D
Common StockMay 3, 2017P1,000$0.08A20,576,949D
Common StockMay 3, 2017P1,000$0.079A20,577,949D
Common StockMay 3, 2017P1,000$0.079A20,578,949D

Table II — derivative securities

No Table II lines on this filing.